GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » Current Deferred Revenue

BioTech Medics (BioTech Medics) Current Deferred Revenue : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTech Medics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

BioTech Medics's current deferred revenue for the quarter that ended in . 20 was $0.00 Mil.

BioTech Medics Current Deferred Revenue Historical Data

The historical data trend for BioTech Medics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics Current Deferred Revenue Chart

BioTech Medics Annual Data
Trend
Current Deferred Revenue

BioTech Medics Quarterly Data
Current Deferred Revenue

BioTech Medics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of BioTech Medics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTech Medics (BioTech Medics) Business Description

Traded in Other Exchanges
N/A
Address
5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.